Potassium Channel Tetramerisation Domain Containing 15 (KCTD15) (C-Term) Peptide
KCTD15
Reactivity: Human
BP
Sodium azide
-
- Target See all KCTD15 products
- KCTD15 (Potassium Channel Tetramerisation Domain Containing 15 (KCTD15))
- Protein Region
- C-Term
- Origin
- Human
- Application
- Blocking Peptide (BP)
- Characteristics
-
16 amino acids near the carboxy terminus of human KCTD15.
Human
-
-
- Application Notes
- KCTD15 peptide is used for blocking the activity of KCTD15.
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 200 μg/mL
- Buffer
- PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1 % bovine serum albumin and 0.02 % sodium azide
- Preservative
- Sodium azide
- Precaution of Use
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Storage
- -20 °C
- Expiry Date
- 12 months
-
- Target
- KCTD15 (Potassium Channel Tetramerisation Domain Containing 15 (KCTD15))
- Synonyms
- BC031749 Peptide, kctd15 Peptide, zgc:100865 Peptide, fa02e12 Peptide, kctd15l Peptide, wu:fa02e12 Peptide, zgc:103747 Peptide, potassium channel tetramerization domain containing 15 Peptide, potassium channel tetramerisation domain containing 15 Peptide, potassium channel tetramerization domain containing 15 L homeolog Peptide, potassium channel tetramerization domain containing 15b Peptide, potassium channel tetramerization domain containing 15a Peptide, KCTD15 Peptide, Kctd15 Peptide, kctd15.L Peptide, kctd15b Peptide, kctd15a Peptide
-
You are here:
